Assessing a Risk Model for G6PD Deficiency

NCT03337152 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

54

Enrollment

OTHER

Sponsor class

Stopped study met study halting rules

Conditions

Malaria, Vivax
G6PD Deficiency

Interventions

DRUG: primaquine
DRUG: chloroquine + primaquine

Sponsor

PATH

Collaborators

[object Object]